tegafur has been researched along with Genetic Predisposition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meulendijks, D | 1 |
| Henricks, LM | 1 |
| Sonke, GS | 1 |
| Deenen, MJ | 1 |
| Froehlich, TK | 1 |
| Amstutz, U | 1 |
| Largiadèr, CR | 1 |
| Jennings, BA | 1 |
| Marinaki, AM | 1 |
| Sanderson, JD | 1 |
| Kleibl, Z | 1 |
| Kleiblova, P | 1 |
| Schwab, M | 1 |
| Zanger, UM | 1 |
| Palles, C | 1 |
| Tomlinson, I | 1 |
| Gross, E | 1 |
| van Kuilenburg, AB | 1 |
| Punt, CJ | 1 |
| Koopman, M | 1 |
| Beijnen, JH | 1 |
| Cats, A | 1 |
| Schellens, JH | 1 |
1 review available for tegafur and Genetic Predisposition
| Article | Year |
|---|---|
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Gas | 2015 |